North America Pharmacogenomics Market Analysis by Opportunities, Sales Revenue 2028


 The North America Pharmacogenomics Market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. it is estimated to grow at a CAGR of 10.1% from 2021 to 2028.

Key Drivers and Strategic Insights for the North America Pharmacogenomics Market

The growth of the North America pharmacogenomics market is primarily driven by three key factors: the rising prevalence of chronic diseases, increasing demand for precision medicine, and significant investments in pharmacogenomic research. However, a critical challenge restraining this growth is the ongoing shortage of skilled professionals in the field.

Chronic diseases remain a major public health concern, particularly among older adults, with more than 60% suffering from two or more chronic conditions. Twin studies and genome-wide association studies (GWAS) have established a strong genetic link to many chronic diseases, including cardiovascular diseases (CVDs), diabetes, obesity, rheumatoid arthritis (RA), Alzheimer’s disease (AD), and depression. With advancements in molecular genetics, individual-level risk assessments for these conditions have become possible, further highlighting the importance of pharmacogenomics.

According to the Centers for Disease Control and Prevention (CDC), in 2020, approximately 60% of people in the US had at least one chronic disease, and 40% suffered from two or more. Cardiovascular diseases—such as atherosclerosis, angina, and myocardial infarction—are among the leading causes of death, claiming around 17.9 million lives annually, as reported by the World Health Organization (WHO).

Diabetes, a major life-threatening condition with no definitive cure, continues to increase in prevalence. It is associated with severe complications, including heart attack, stroke, kidney failure, amputation, nerve damage, and vision loss. The International Diabetes Federation (IDF) reported 46 million diabetic patients in North America in 2017, with projections estimating 62 million by 2045. Globally, the number of people with diabetes is expected to rise from 425 million in 2017 to 629 million by 2045, marking a ~35% increase during the forecast period.

Alzheimer’s disease also presents a significant healthcare burden, with an estimated 55 million cases globally in 2020, according to the Alzheimer’s Association. As these chronic conditions surge, the need for targeted, genomics-based therapies has accelerated, fueling the growth of the North America Pharmacogenomics Market.

Governments and private sector stakeholders have responded with substantial investment. National genomic medicine initiatives across at least 14 countries have collectively attracted over US$ 4 billion in funding. These initiatives are actively integrating pharmacogenomics into clinical practice, driving real-world implementation, and overcoming barriers to broader adoption.

In August 2018, Boston Scientific Corporation, based in Massachusetts, secured US$ 4.3 million in seed funding and formed a strategic partnership with Veritas Genetics. This initiative aims to advance personal genome sequencing through a secure, decentralized marketplace for genomic data—demonstrating how private investment is accelerating North America Pharmacogenomics Market development.

Strategic Outlook for North America Pharmacogenomics Market

Strategic insights into the North America pharmacogenomics market reveal an evolving landscape marked by innovation, investment, and regional specificity. Industry players—including investors, manufacturers, and healthcare providers—can leverage data-driven analytics to identify untapped market segments, develop distinctive value propositions, and stay ahead of emerging trends.

By anticipating market shifts and embracing precision medicine, stakeholders can position themselves for sustainable growth. Strategic foresight and informed decision-making will be essential for navigating this dynamic and rapidly evolving market, ensuring long-term success and profitability.

NORTH AMERICA PHARMACOGENOMICS MARKET SEGMENTATION

North America Pharmacogenomics Market By Technology

  • Hospitals & Clinics
  • Biopharmaceutical Companies
  • CROs and CDMOs
  • Others

North America Pharmacogenomics Market By Application

  • PCR
  • Sequencing
  • Microarray
  • gel electrophoresis
  • mass spectrometry
  • Others 

North America Pharmacogenomics Market By End User

  • Drugs Discovery
  • Oncology
  • Neurological & Psychiatry
  • Pain Management
  • Cardiovascular
  • Others

North America Pharmacogenomics Market By Country

  • US
  • Canada
  • Mexico

North America Pharmacogenomics Market Company Profiles

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD.
  • Oxford Nanopore Technologies
  • THERMO FISHER SCIENTIFIC INC.
  • Illumina, Inc.
  • QIAGEN
  • Agilent Technologies, Inc.
  • Myriad Genetics, Inc.
  • Admera Healt

Other Reports: 

North America Dolomite Market: https://postyourarticle.com/north-america-dolomite-market-future-growth-business-prospects-by-2028/ 

North America Recovered Carbon Black Market: https://penzu.com/p/fcd4e14aa6320fdf  

North America Medical Aesthetics Market: https://business-news-insights.blogspot.com/2025/04/north-america-medical-aesthetics-market.html 

North America Automotive Lead Acid Battery Market: https://sites.google.com/view/automotive-lead-acid-battery/home 

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market Insights

Comments

Post a Comment

Popular posts from this blog

North America Small Satellite Market Trends, Opportunity and Forecast 2022 to 2028

Image
The  North America Small Satellite Market  is expected to grow from US$ 1,325.42 million in 2022 to US$ 4,976.36 million by 2028; it is estimated to grow at a CAGR of 24.7% from 2022 to 2028. Growing Support for Small Satellite Development Governments and companies across North America are increasingly investing in the small satellite market to meet the growing demand for applications such as Earth observation, communication, navigation, and scientific research. In November 2021, Fleet Space Technologies secured $26 million in funding to expand its nanosatellite IoT connectivity fleet. Such investments from both public and private sectors are fueling market growth. Small satellites play a crucial role in enhancing national security, monitoring disaster-affected areas, tracking suspicious maritime activities, and supporting communication and scientific research. To further boost the industry, governments are promoting initiatives for rapid construction and domestic production o...
Read more

North America Small Satellite Market Current Status by 2028 Top Players

Image
The  North America small satellite market  is expected to grow from US$ 1,325.42 million in 2022 to US$ 4,976.36 million by 2028; it is estimated to grow at a CAGR of 24.7% from 2022 to 2028. Rising Support for Small Satellite Development In North America, both government entities and private companies are increasingly investing in the small satellite market, driven by growing demand across diverse applications such as Earth observation, communications, navigation, and scientific research. For example, in November 2021, Fleet Space Technologies secured US$26 million in funding to enhance its nanosatellite IoT connectivity network. Such initiatives reflect the strong governmental and private sector backing that is fueling the North America small satellite market growth. Small satellites play a critical role in national security, disaster response (e.g., monitoring earthquake or flood-affected regions), maritime surveillance, and support for communication, navigation, and resear...
Read more

Europe Bathroom Vanities Market Key Players Analysis, Forecast 2028

Image
The  Europe Bathroom Vanities Market  is expected to grow from US$ 14,065.11 million in 2021 to US$ 17,057.14 million by 2028. It is estimated to surge at a CAGR of 2.8% from 2021 to 2028. Growth of Online Retailing in Europe Bathroom Vanities Market The rise of online retailing is significantly driving the expansion of the Europe Bathroom Vanities Market. Consumers are increasingly shifting from traditional purchasing methods to virtual shopping due to the convenience it offers and its broader reach. Advancements in telecommunication infrastructure have made the Internet more accessible, enabling a growing number of users to explore and purchase bathroom vanities online. Online shopping platforms provide consumers with a wide selection of products, complete with detailed specifications and price comparisons. The seamless, end-to-end buying process eliminates the need for physical effort or travel, saving time while enhancing the shopping experience. This shift toward digital ...
Read more